FSD Pharma Inc.
NASDAQ:HUGE
Overview | Financials
Company Name | FSD Pharma Inc. |
Symbol | HUGE |
Currency | USD |
Price | 0.09 |
Market Cap | 66,671 |
Dividend Yield | 0% |
52-week-range | 0.087 - 109.193 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Zeeshan Saeed |
Website | https://www.fsdpharma.com |
An error occurred while fetching data.
About FSD Pharma Inc.
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD